Experimental drug tested for Parkinson's brain fog
NCT ID NCT04476017
Summary
This study tested the safety and side effects of an experimental drug called SAGE-718 in people with Parkinson's disease who have mild thinking and memory problems. Eighteen participants with early to moderate Parkinson's took the drug to see how well they tolerated it and whether it might help with cognitive, mood, and movement symptoms. The main goal was to check for safety, not to prove the drug works for treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Long Beach, California, 90806, United States
-
Sage Investigational Site
Port Charlotte, Florida, 33980, United States
-
Sage Investigational Site
West Palm Beach, Florida, 33407, United States
-
Sage Investigational Site
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.